ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 78 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,811,612 | -22.8% | 420,900 | -3.0% | 0.01% | -22.2% |
Q2 2023 | $3,641,260 | -30.5% | 434,000 | -17.8% | 0.01% | -35.7% |
Q1 2023 | $5,242,047 | +27.6% | 527,900 | -10.5% | 0.01% | +27.3% |
Q4 2022 | $4,107,096 | -14.3% | 590,100 | -34.3% | 0.01% | -21.4% |
Q3 2022 | $4,793,000 | +35.4% | 897,600 | +1.2% | 0.01% | +40.0% |
Q2 2022 | $3,539,000 | +56.8% | 887,000 | +74.7% | 0.01% | +66.7% |
Q1 2022 | $2,257,000 | -18.1% | 507,700 | -26.3% | 0.01% | -14.3% |
Q4 2021 | $2,757,000 | -60.2% | 689,200 | -12.6% | 0.01% | -61.1% |
Q3 2021 | $6,922,000 | -39.8% | 788,400 | -22.4% | 0.02% | -40.0% |
Q2 2021 | $11,506,000 | +15.9% | 1,015,500 | +21.6% | 0.03% | +11.1% |
Q1 2021 | $9,925,000 | +114.9% | 835,400 | +24.1% | 0.03% | +125.0% |
Q4 2020 | $4,619,000 | +3.8% | 673,300 | +12.1% | 0.01% | -7.7% |
Q3 2020 | $4,450,000 | +1286.3% | 600,600 | +680.0% | 0.01% | +1200.0% |
Q2 2020 | $321,000 | +277.6% | 77,000 | +124.5% | 0.00% | – |
Q1 2020 | $85,000 | +44.1% | 34,300 | +239.6% | 0.00% | – |
Q4 2019 | $59,000 | – | 10,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPHERA FUNDS MANAGEMENT LTD. | 1,009,131 | $7,568,000 | 1.15% |
Knoll Capital Management, LLC | 124,096 | $931,000 | 0.96% |
683 Capital Management, LLC | 1,000,000 | $7,500,000 | 0.66% |
Perceptive Advisors | 3,085,458 | $23,141,000 | 0.65% |
MANGROVE PARTNERS IM, LLC | 324,019 | $2,430,000 | 0.16% |
Stanley-Laman Group, Ltd. | 64,029 | $480,000 | 0.11% |
WOODSTOCK CORP | 67,759 | $508,000 | 0.10% |
Hikari Power Ltd | 107,858 | $809,000 | 0.10% |
ARDSLEY ADVISORY PARTNERS LP | 45,000 | $336,000 | 0.05% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 750,000 | $5,625,000 | 0.01% |